GE Hitachi, the nuclear business of GE Vernova, will invest over $50m at its nuclear fuel manufacturing plant in Wilmington, ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

Novo Holdings last month closed a $16.5 billion deal to buy U.S.-based Catalent. The firm then sold three of Catalent's plants used to complete the drug manufacturing process to Novo Nordisk for $ ...

Danish multinational pharmaceutical giant Novo Nordisk is the sole owner of semaglutide, the active ingredient in both Ozempic and Wegovy. A month’s supply of Ozempic is close to $1,000 without ...

Novo Nordisk likely benefits from adding manufacturing capacity for its blockbuster drugs Wegovy and Ozempic by making this acquisition. By gaining ownership of Catalent plants, Novo Nordisk can ...

Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for legal issues in China. One of these stocks has a stronger investment ...

Novo Nordisk also boasted a 55.6% share of the GLP-1 drug space, compared to 54.4% as of August 2023. The company's most famous brands, Wegovy and Ozempic, are both GLP-1s.

Toyota has committed to using 100% renewable energy to produce batteries at the North Carolina plant, which has been under construction since 2021. The automaker has been accused by environmental ...

To hear Novo tell it, the outsourcing group OFA shouldn’t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available. Further, the OFA has ...